Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

102.81
Delayed Data
As of May 18
 +1.17 / +1.15%
Today’s Change
62.96
Today|||52-Week Range
153.99
-19.08%
Year-to-Date

Stock Price Forecast

The 16 analysts offering 12-month price forecasts for Alnylam Pharmaceuticals Inc have a median target of 143.00, with a high estimate of 207.00 and a low estimate of 86.00. The median estimate represents a +39.09% increase from the last price of 102.81.

Analyst Recommendations

The current consensus among 17 polled investment analysts is to Buy stock in Alnylam Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$1.79
Sales
$18.5M
Reporting Date
Aug 09

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -26.65%
 
 
 
 
 
 
Growthannually -30.41%
 
 
 
 
 
 

Sales

Growthquarterly -15.57%
 
 
 
 
 
 
Growthannually 16.89%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.